Fierce Pharma
NOVEMBER 21, 2024
Few pharmaceutical products have taken the market by storm like Roche’s Vabysmo. | Interim results from a late-stage trial of Roche's Vabysmo on Asian patients with polypoidal choroidal vasculopathy suggest that the injected treatment is effective. After 16 weeks, patients showed vision improvement which was equivalent to reading roughly one and a half more lines on an eye chart.
MedCity News
NOVEMBER 21, 2024
New advancements can only be fully realized when clinicians, lawmakers, and patients come together. Biomarker tests not only have the potential to improve patient outcomes and address health equity, they can also decrease expenses for financially vulnerable medical systems. The post Eliminating Barriers and Increasing Access to New Testing to Improve Prenatal Care appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 21, 2024
As he introduced Novartis’ meet-the-management event Thursday in London, CEO Vas Narasimhan hammered home Novartis’ status as a streamlined, “pure-play, innovative medicines” company and the succes | Novartis has adjusted its compound annual growth rate expectation from 5%-plus to 6%-plus through 2029. The Swiss company cited the momentum of its current growth drivers, which have paved the way for a strong sales performance this year.
PharmaVoice
NOVEMBER 21, 2024
A subcutaneous version of Merck’s Keytruda was as effective as the infused version in a late-stage study, but the company won’t be the first to market.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
NOVEMBER 21, 2024
Merck and Johnson & Johnson are cutting staffers in China as they face local headwinds | Merck and Johnson & Johnson are cutting staffers in China as they face local headwinds, according to reports. Australia’s CSL is winding down operations at a cell and gene therapy R&D site in California. Kyowa Kirin inked a commercialization and development deal with Kuro Oncology.
MedCity News
NOVEMBER 21, 2024
Reducing diagnostic error is a significant part of healthcare organizations’ efforts to improve patient outcomes. By using data to recognize vulnerabilities in the diagnostic process, empowering their diagnostic teams and fostering an environment where every team player understands their vital role organizations can proactively correct the potential root causes of diagnostic errors.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
NOVEMBER 21, 2024
Kura Oncology already had a broad development plan for ziftomenib in leukemias, but the agreement with Kyowa Kirin provides the cash to execute it and a partner to commercialize the drug globally. Ziftomenib is in the same class of medicines as Syndax Pharmaceuticals’ Revuforj, which won FDA approval last week. The post Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin appeared first on MedCity News.
European Pharmaceutical Review
NOVEMBER 21, 2024
Accessibility, as well as optimised nutrient and medicine release, are the driving forces behind modernising drug delivery. With millions around the world struggling with dysphagia and other conditions that affect their ability to take pills and other medications, innovative delivery methods with gel-based platforms are necessary to promote greater accessibility and medication adherence.
pharmaphorum
NOVEMBER 21, 2024
Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
European Pharmaceutical Review
NOVEMBER 21, 2024
In June, the US Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) rejected 1 Lykos Therapeutics’ psychedelic new drug application (NDA) for midomafetamine (MDMA) capsules used alongside MDMA-assisted therapy to treat post-traumatic stress disorder (PTSD) in adults. With the recent failure of Lykos’ trial, how do you see the future of psychedelic therapies in research, especially in treating disorders like depression, PTSD, and substance use diso
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
NOVEMBER 21, 2024
Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML
pharmaphorum
NOVEMBER 21, 2024
Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug.
European Pharmaceutical Review
NOVEMBER 21, 2024
Several new appointments were announced by Amgen and Pfizer yesterday, focusing on R&D functions. Pfizer Inc. is appointing Dr Chris Boshoff , PhD, as Chief Scientific Officer and President, Research & Development. Dr Boshoff will begin this new role on 1 January 2025 and will oversee all R&D functions across every therapeutic area in the company.
pharmaphorum
NOVEMBER 21, 2024
Shares in genetic testing company 23andMe continue to slide after prominent investors announce plans to sell their stakes.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Technology
NOVEMBER 21, 2024
Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.
pharmaphorum
NOVEMBER 21, 2024
Novartis buys gene therapy specialist Kate Therapeutics for $1.
PM360
NOVEMBER 21, 2024
Corcept Therapeutics Corcept Therapeutics is a pharmaceutical company focused on unlocking the potential of cortisol modulation. In late 2022, Corcept’s marketing team found itself at a critical juncture in the dozen-year-long history of its established brand, Korlym®. A rapidly changing clinical landscape and new competitive entrants had threatened Korlym’s established positioning in the marketplace.
Contrarian Sales Techniques
NOVEMBER 21, 2024
If you’re considering a career in medical sales with a multinational pharmaceutical (MNC) company in Malaysia, you might be in for an exciting journey. These companies are known for their innovation, global reach, and competitive perks. But working for an MNC comes with its own set of unique opportunities and challenges that aren’t always obvious at first glance.
PM360
NOVEMBER 21, 2024
Tarsus Pharmaceuticals TEAM MEMBERS: Matt Rossen Vice President, Marketing. Jason Alongi Senior Director, Consumer Marketing. Mika Thorley Director, Consumer Marketing. The XDEMVY Consumer Marketing Team from Tarsus was tasked with priming the market for the first and only FDA-approved Demodex blepharitis treatment. They worked tirelessly in creating and executing two distinct innovative and impactful complementary campaigns: the “Don’t Freak Out, Get Checked Out” disease education campaign and
Pharmaceutical Commerce
NOVEMBER 21, 2024
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, outlines the steps that pharma leaders should keep in mind to when combatting supply chain issues.
PM360
NOVEMBER 21, 2024
Winning a Lifetime Achievement Award after 40+ Years of Leadership Labcorp’s Adam Schechter was presented a Lifetime Achievement Award at the 2024 Trailblazer Awards, which took place at Gotham Hall in New York City, October 1. This honor truly commended a lifetime of leadership. Adam became CEO of Labcorp in 2019 and Chairman of the Board in 2020. Prior to that, he was named Lead Independent Director in 2019 after serving as a director of the company since 2013.
Clarify Health
NOVEMBER 21, 2024
Following record healthcare spending of $4.5 trillion in 2024 —of which one-third was classified as wasteful—healthcare systems face mounting pressure to improve efficiency and cut costs without sacrificing quality. According to research from PwC, medical costs alone are projected to rise 7–8% in 2025 , marking the highest increase in over 13 years.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PM360
NOVEMBER 21, 2024
Neurocrine Biosciences, Inc. is a leading neuroscience-focused, biopharmaceutical company headquartered in San Diego, CA, with a single purpose: to relieve suffering for people with great needs but few options. Neurocrine Biosciences was founded in 1992 and has grown today to 1,436 U.S.-based employees who are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders.
PharmExec
NOVEMBER 21, 2024
Jazz Pharmaceuticals' Ziihera (zanidatamab-hrii) provides a chemotherapy-free treatment option for patients with HER2-positive biliary tract cancer, addressing a critical unmet need with promising efficacy and improved quality of life.
PM360
NOVEMBER 21, 2024
embecta is a leading global diabetes care company, serving over 30 million individuals in more than 100 countries. With a 100-year legacy in insulin delivery, embecta continues to innovate in diabetes management, a disease affecting over 537 million people worldwide. Innovation An independent company after spinning off from Becton Dickinson in 2022, embecta embodies the spirit of a “100-yearold startup.
Contrarian Sales Techniques
NOVEMBER 21, 2024
For many patients in Malaysia, accessing essential medications can be a financial burden. This is where drug access programs step in, offering affordable or even free treatments for chronic and life-threatening conditions. For pharma sales reps, these programs are not just tools for market penetration – they’re lifelines that improve healthcare accessibility across the country.
PM360
NOVEMBER 21, 2024
Elevate cofounders Frank X. Powers and Lorna Weir envisioned a successful, independent agency that was an alternative for clients and brands who needed individual attention from a team of deeply experienced strategic, scientific, and creative professionals. Fast-forward 8 years, and their vision has been realized as Elevate has ascended from their idea to become a prominent force in healthcare marketing.
European Pharmaceutical Review
NOVEMBER 21, 2024
Articles in Issue 5 of European Pharmaceutical Review include: FOREWORD ICH Q6(R1): test criteria and specifications Dave Elder David P Elder Consultancy CELL & GENE THERAPY How automation and digital technologies will unlock the full potential of advanced therapies Dr Stephen Ward CGT Catapult Hydrogel encapsulation: unlocking the potential of cell therapies for targeted treatments Dr Stephen Harrington and Francis Karanu Likarda SUSTAINABILITY Transitioning to digital product information t
Contrarian Sales Techniques
NOVEMBER 21, 2024
Medical reps in Malaysia don’t just sell products – they educate. From explaining how a medication works to addressing patient concerns, reps play a vital role in bridging the gap between healthcare providers and patients. In a country as diverse as Malaysia, where healthcare literacy varies, this role becomes even more critical. The Role of Medical Reps in Patient Education Patient education isn’t just about handing out brochures.
European Pharmaceutical Review
NOVEMBER 21, 2024
Nowadays it is not uncommon to see “help wanted” signs in storefront windows. The current labour shortage has impacted many quality control (QC) microbiology labs, just like any other industry, which results in overworked and unsatisfied employees. However, outsourcing microbial identification is a tried-and-true method to save time by placing attention on other high value tasks, while simultaneously relieving overworked employees, leading to increased retention.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
261 
Let's personalize your content